Fundz

Syndevrx Inc reported raising $500,000 in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEMar 21, 2018$500K of $5M raised

Amount Raised

$500,000

$500,000 sold, per SEC Form D (first sale Mar 21, 2018)

Round Type

Venture

CambridgeBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Syndevrx that raised within 45 days of this round, from Fundz verified event records.

  • TELA Bio raised $240K (Seed) on May 4, 2018.
  • GenoPalate raised $357K (Seed) on May 3, 2018.
  • valisure llc raised $300K (Seed) on May 3, 2018.
  • ProMIS Neurosciences raised $1.7M on May 3, 2018.
  • Mellitus, LLC raised $5.6M on May 3, 2018.
  • NutriBand Inc. raised $1M (Seed) on May 3, 2018.

Who to call at Syndevrx, and when

A new round usually means Syndevrx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Syndevrx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syndevrx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syndevrx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syndevrx

Location

ONE BROADWAY

Cambridge, Massachusetts, United States

About

SynDevRx has offices in Scottsdale Arizona and Cambridge Massachusetts. Our team has decades of oncology drug development expertise. Our goal is to develop novel drug conjugates and commercialize them through partnerships with industry leaders. Here at SynDevRx, we believe that success comes from a balanced combination of leading technology andtalented people with synergistic skills. Our combination of best-in-class technology, a world-class SAB comprised of world Key Opinion Leaders in clinical oncology, a team of senior drug development professionals delivers high-value solutions to patients and investors alike.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syndevrx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBradley C., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Syndevrx's next move

See what Strategic adds

Syndevrx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.